Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | EXP | | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of NSMAF mRNA | CTD | PMID:24763279 | 1,2-dimethylhydrazine | multiple interactions | ISO | Nsmaf (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of NSMAF mRNA | CTD | PMID:22206623 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of NSMAF mRNA | CTD | PMID:29581250 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NSMAF mRNA | CTD | PMID:23152189 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nsmaf (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NSMAF mRNA | CTD | PMID:21570461 and PMID:26377647 | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of NSMAF mRNA | CTD | PMID:37199045 | acrylamide | increases expression | ISO | Nsmaf (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of NSMAF mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of NSMAF mRNA | CTD | PMID:32763439 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of NSMAF mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to NSMAF mRNA] | CTD | PMID:32406909 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of NSMAF mRNA | CTD | PMID:22378314 | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of NSMAF mRNA | CTD | PMID:19162166 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of NSMAF mRNA | CTD | PMID:20106945 and PMID:21632981 | benzo[a]pyrene | increases methylation | ISO | Nsmaf (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of NSMAF intron | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | Nsmaf (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of NSMAF mRNA | CTD | PMID:25181051 and PMID:27571134 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NSMAF gene | CTD | PMID:31601247 | bisphenol A | affects expression | ISO | Nsmaf (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of NSMAF mRNA | CTD | PMID:30816183 | carbon nanotube | decreases expression | ISO | Nsmaf (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of NSMAF mRNA | CTD | PMID:20106945 | dieldrin | affects expression | ISO | Nsmaf (Rattus norvegicus) | 6480464 | Dieldrin affects the expression of NSMAF mRNA | CTD | PMID:22546817 | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of NSMAF mRNA | CTD | PMID:35967413 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NSMAF mRNA | CTD | PMID:27188386 | doxorubicin | affects response to substance | EXP | | 6480464 | NSMAF protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of NSMAF mRNA | CTD | PMID:29803840 | elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of NSMAF mRNA | CTD | PMID:19244175 | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of NSMAF mRNA | CTD | PMID:27188386 | fipronil | decreases expression | ISO | Nsmaf (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of NSMAF mRNA | CTD | PMID:34044035 | folic acid | multiple interactions | ISO | Nsmaf (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of NSMAF mRNA | CTD | PMID:22206623 | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NSMAF gene | CTD | PMID:31601247 | irinotecan | decreases expression | EXP | | 6480464 | Irinotecan results in decreased expression of NSMAF mRNA | CTD | PMID:20185912 | isoprenaline | multiple interactions | ISO | Nsmaf (Rattus norvegicus) | 6480464 | [Isoproterenol co-treated with POSTN protein] results in decreased expression of NSMAF mRNA | CTD | PMID:30303030 | methamphetamine | increases expression | ISO | Nsmaf (Mus musculus) | 6480464 | Methamphetamine results in increased expression of NSMAF mRNA | CTD | PMID:26307267 | p-menthan-3-ol | increases expression | EXP | | 6480464 | Menthol results in increased expression of NSMAF mRNA | CTD | PMID:26760959 | panobinostat | multiple interactions | EXP | | 6480464 | (+)-JQ1 compound promotes the reaction [panobinostat affects the expression of NSMAF mRNA] and panobinostat promotes the reaction [(+)-JQ1 compound affects the expression of NSMAF mRNA] | CTD | PMID:26733615 | panobinostat | affects expression | EXP | | 6480464 | panobinostat affects the expression of NSMAF mRNA | CTD | PMID:26733615 | paracetamol | affects expression | ISO | Nsmaf (Mus musculus) | 6480464 | Acetaminophen affects the expression of NSMAF mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | Nsmaf (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of NSMAF mRNA | CTD | PMID:33387578 | perfluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of NSMAF mRNA | CTD | PMID:32588087 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NSMAF mRNA | CTD | PMID:19710929 | propionic acid | decreases expression | EXP | | 6480464 | propionic acid results in decreased expression of NSMAF mRNA | CTD | PMID:31526819 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NSMAF mRNA | CTD | PMID:27188386 | selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of NSMAF mRNA | CTD | PMID:19244175 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of NSMAF mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of NSMAF mRNA | CTD | PMID:31758290 | tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of NSMAF mRNA | CTD | PMID:15336504 | tetrachloromethane | increases expression | ISO | Nsmaf (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of NSMAF mRNA | CTD | PMID:31919559 | tetraphene | increases expression | ISO | Nsmaf (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of NSMAF mRNA | CTD | PMID:26377693 | topotecan | affects response to substance | EXP | | 6480464 | NSMAF protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of NSMAF mRNA | CTD | PMID:24935251 | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of NSMAF mRNA | CTD | PMID:28542535 | valproic acid | decreases expression | ISO | Nsmaf (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of NSMAF mRNA | CTD | PMID:21427059 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NSMAF mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of NSMAF mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NSMAF mRNA | CTD | PMID:25979313 | vincaleukoblastine | affects response to substance | EXP | | 6480464 | NSMAF protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of NSMAF mRNA | CTD | PMID:27188386 | zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of NSMAF mRNA | CTD | PMID:16330358 | |